Anal cancer squamos cell carcinoma stage 3b bca2 and atm mutations
According to the NCCN Guidelines for Anal Carcinoma (2023):
- Stage 3B anal cancer is typically treated with a combination approach called "combined modality therapy" which includes: • Concurrent chemoradiation (radiation therapy given together with chemotherapy) • The standard chemotherapy combination is 5-FU plus mitomycin
The National Cancer Institute (NCI) notes that for locally advanced anal cancer (Stage 3B):
- Treatment typically lasts 5-6 weeks
- This approach has been shown to be effective in treating anal cancer while preserving organ function
- Regular monitoring during and after treatment is essential
Regarding your BRCA2 and ATM mutations, the ASCO Guidelines indicate:
- These mutations affect DNA repair pathways
- Patients with these mutations may respond particularly well to certain treatments like PARP inhibitors
- Genetic counseling is recommended to understand implications for both treatment and family members
Important recommendations:
- Work closely with your oncology team to develop a personalized treatment plan
- Consider genetic counseling if you haven't already done so
- Ask your doctor about clinical trials, as new treatments targeting BRCA2 and ATM mutations are being studied
Would you like me to provide more specific information about any of these aspects of your care? I can share additional details about treatment protocols or side effect management from these trusted sources.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
- Anal cancer squimish cell carcinoma and in immense pain. the worst is when i go to the bathroom . pooping feels...
- Pros and cons for cisplatin vs mitomicin for my diagnosis given my genetic mutations - i have anal cancer squamos...
- Brca2 and atm genetic mutations. should i consider cisplatin for chemo
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Colon Cancer — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated October 15, 2025. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Colon Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with diagnosis for Colorectal Cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Colorectal Cancer
- What does KRAS mutation mean in cancer
- How does CAR-T cell therapy work for Colorectal Cancer
- How do I know if my Colorectal Cancer has an actionable mutation
- What does TP53 mutation mean for Colorectal Cancer prognosis
- What does BRAF V600E mutation mean for my Colorectal Cancer
- What does EGFR mutation mean for Colorectal Cancer treatment
- What foods help boost white blood cells during Colorectal Cancer treatment
- What genetic mutations are commonly found in Colorectal Cancer